Saturday, Jun 20, 2026
Breaking
Search
Home
Business
Entertainment
News
Sports
Tech
World
Explore by Topics
Subscribe
Search
Business
Entertainment
News
Sports
Tech
World
Subscribe Newsletter
Daily Stories
Stock Alerts
Full Access
Subscribe to our newsletter to get our newest articles instantly!
I have read and agree to the terms & conditions
Novo
Business
Novo Nordisk and Hims Resolve Ozempic Dispute: Impact on Consumers
March 11, 2026
Business
Citi Upgrades Hims & Hers Health After Novo Nordisk Partnership
March 10, 2026
Business
Orforglipron Outperforms Novo Nordisk’s GLP-1 Pill in Eli Lilly Tests
February 27, 2026
Business
Novo Nordisk Partners with Langer Biotech for Oral Obesity Drugs
February 25, 2026
Business
Novo Nordisk Reduces Wegovy Prices by 50% and Ozempic by 35%
February 25, 2026
Business
Novo Nordisk Cuts US List Prices for Ozempic and Wegovy
February 25, 2026
Business
FDA Authorizes Novocure’s New Device to Prolong Pancreatic Cancer Survival
February 22, 2026
Business
Novo Nordisk Sues Competitor Over ‘Knock-Off’ Weight-Loss Drugs
February 10, 2026
Business
Novo Nordisk Sues Hims Over FDA-Controversial $49 Weight-Loss Pill
February 10, 2026
Business
FDA Criticizes Novo’s Obesity Pill TV Ad for Misleading Claims
February 10, 2026
Business
Novo Nordisk Sues Hims to Stop Obesity Drug Imitations
February 10, 2026
Business
Hims & Hers Halts Sale of Novo’s Compounded Obesity Pill
February 8, 2026
Show More
Loading...
